Log In

Healthcare & Pharmaceuticals Blog

Recent Posts

  • Blog: Biologics BlogPart I: Stakeholder Comments on FDA’s Interchangeability Guidance for BiosimilarsPosted on May 22, 2017 by
    The comment period for FDA’s draft guidance Considerations in Demonstrating Interchangeability With a Reference Product closed on Friday, May 19, 2017.  Innovators, biosimilar makers, patients, healthcare providers and other stakeholders have weighed in on the long-awaited guidance.  Interchangeable biosimilars, unlike other biosimilars, may be substituted for the innovator product without the intervention of the healthcare [...]
  • Blog: Biotech Business LawyerGenetically Modified Rice vs. ChinaPosted on March 11, 2013 by biotechbusinesslawyer
    A March 7, 2013 piece on Morning Edition, the morning news program from National Public Radio, raised a lot of questions. “In A Grain Of Golden Rice, A World Of Controversy Over GMO Foods” told the story of golden rice, … Continue reading →

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | DISCLAIMER |  © World Services Group, 2017